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ABSTRACT Carbon-13 nuclear magnetic resonance
spectra have been obtained for the coumarin-related com-
pounds warfarin and phenprocoumon. The spectral
assignments indicate that warfarin exists as a mixture
of cyclic hemiketal diastereomers in dimethyl sulfoxide
solution. The sodium salt of warfarin exists as the ring-
open form in water solution.
Warfarin has been used as a rodenticide and anticoagulant
since the late 1940's, while the sodium salt of warfarin
(Coumadin®) has become the most widely used anticoagulant
in many hematological diseases and surgical procedures. The
rationale for structures 1 and 2 assigned to warfarin and its
sodium salt, respectively, has come from chemical synthesis
(1) and spectroscopic methods (2). These structures have
been assumed to be correct for many years, although no
rigorous structural proof has as yet been presented in the
literature. Recently, it has been suggested that crystalline
warfarin exists as the hemiketal, 3. (Diffraction data in-
dicates a cyclic hemiketal structure in the solid state; E.
Valente, W. F. Trager, and L. H. Jenson, personal com-
munication and paper submitted for publication.)
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Clearly, structural information for the dissolved substance is of
great interest and importance to those concerned with the
mode of action of warfarin.
Solution studies of warfarin utilizing infrared and proton
nuclear magnetic resonance (NMR) spectra, are difficult to
interpret and are ambiguous due to the complexity of the
spectra, although the proton NMR spectrum of warfarin is
similar to that of the cyclocoumarol, 4 (K. K. Chan, un-
published data). This fact suggests that the keto structure 1 for
warfarin in solution may also be incorrect. Much more defini-
tive information seemed possible through use of carbon-13
NMR to differentiate between structures 1 and 3 because the
hemiketal carbon (3, position 13) would have a grossly dif-
Abbreviations: NMR, nuclear magnetic resonance; TMS,
tetramethylsilane; Me2SO, dimethyl sulfoxdde.
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ferent chemical shift than a keto carbon (1, position 13; 2,
position 13).
EXPERIMENTAL
The samples used in this work were synthesized or were gifts
of Dr. W. F. Trager. Most solutions were 0.75M in dimethyl
sulfoxide-d4. Tetramethylsilane (TMS) was used as the in-
ternal standard. Sodium warfarin was, however, investigated
in water because of its low solubility in dimethyl sulfoxide.
For it, the field-frequency stability was achieved by locking
onto an external deuterium oxide sample which contained
dioxane (13% v/v) to act as the external standard.
Chemical-shift measurements were made using a Brukarian,
pulsed FT spectrometer (3) operating at 15.09 MHz for car-
bon-13. The temperature was maintained at 37.0 i 1° with a
Bruker B-ST temperature control unit. Off-resonance and a
gated-decoupling (4) technique which turns off the proton noise
decoupler during acquisition of data were used in facilitating
spectral assignments. A typical spectrum was run with an
acquisition time of 0.8 sec, pulse delay of 1.0 sec, sweep width
of 5000 Hz and 8K data points.
RESULTS AND DISCUSSION
The assignment of spectral peaks is based on several well-
established methods which are now common in 18C spectros-
copy (for discussion see refs. 5 and 6). For example, the alkyl
carbons, Cli, C12, and C14, are known to have character-
istic chemical shifts (4) based upon model studies with hydro-
carbons. The peaks can be further differentiated by the multi-
plicity patterns obtained from off-resonance experiments.
However, ambiguities were encountered for warfarin and, for
example, the C2 and C4 peaks were not assignable by analogy
with the resonances of coumarin or 4-hydroxycoumarin.
Also, off-resonance did not provide sufficient information to
differentiate between the peaks of C3 and C13. It is known
that proton-carbon spin-spin splittings for a given carbon-13
nucleus can be retained while maintaining high nuclear Over-
hauser enhancement by using gated decoupling (4). And,
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t Samples of phenprocoumon and 30% carbon-13 enriched C2-
phenprocoumon were generously provided by Prof. W. F. Trager
and Mr. William Porter, University of Washington, Seattle.
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FIG. 1. Upfield part of the carbon-13 spectra of warfarin (A), cyclocoumarol (B), sodium warfarin (C), and phenprocoumon X(D). The
septet centered at 39.5 ppm in spectra A, B, and D arises from the dimethyl sulfoxide-d6 (Me2SO-d.) used as solvent.
with this technique, C2 and C4 could be differentiated, be-
cause C4 is coupled to more protons than C2 and thus gives
a broad singlet. The resonances of C3 and C19 were similarly
assigned by correlating the multiplicities of their resonances
with the number of neighboring protons for structure 3. The
assignment of C2 and C4 in phenprocoumon, 5, was made by
comparing natural-abundance 5 with the material labeled
with 'IC at C2.
The structural assignment of neutral warfarin was especially
facilitated by comparisons with the known cyclic compound,
cyclocoumarol, 4, and of the sodium salt, 2, with phen-
procoumon, 5. The upfield region of the carbon-13 spectra
(0-110 ppm) which is most informative for structure elucida-
tion in these compounds is shown in Fig. 1 and the assign-
ments for the various signals are presented in Table 1§.
§ A complete discussion of the assignments for the entire spec-
trum of each compound will be presented in a-forthcoming paper.
The chemical shifts are also given for the ring-junction car-
bons, C3 and C4, which are far downfield and not shown in
Fig. 1.
Cyclocoumarol 4 has two asymmetric centers (C11 and
C13) and, therefore, two pairs of enantiomers are theoretically
possible and two signals in the carbon-13 spectrum would be
expected for each carbon. However, the bulky phenyl group
at Cll should prefer an equatorial placement and thus, when
the monomethoxy-ketal, 4, is formed, one diastereomer is
expected to be favored. It is indeed observed that there is a
small second peak associated with each aliphatic carbon
resonance in the carbon-13 spectrum. The methoxy "doublet"
at 49.5 and 48.9 ppm indicates that the downfield peak of this
pair is due to the major component. Axial methoxy carbons in
cyclic systems have been observed to have upfield chemical
shifts relative to equatorial methoxy carbons in carbon-13
spectroscopy (7). Because the larger peak (49.5 ppm) is down-
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TABLE 1. Carbon-13 chemical shifts of warfarin and relkted
compounds*t
Carbon 2 3 4 5
C3 103.4 101.3 (102.0) 102.5 (102.7) 107.9
C4 175.7 158.8 (159.4) 157.8 (158.3) 160.7
ClH 36.1 35.2 (36.1) 35.1 (34.8) 41.7
C12 46.6 42.9 (41.5) 42.5 (39.2) 23.6
C13 216.5 99.6 (103.4) 101.5 (104.7) 12.7
C14 30.3 27.3 (25.9) 21.7 (22.0)
-OCH3 49.5 (48.9)
* Chemical shifts are in ppm from internal TMS except for
compound 2 whose chemical shifts were measured with external
dioxane and converted to the TMS scale using the factor 67.4
ppm.
t Two chemical shifts are given for samples which contain a
mixture of diastereomers. Those for the minor component are
given in parentheses.
field for this pair it is concluded that the methoxy group on
C13 is preferentially equatorial (3:1). The ratio of the peak
intensities in the other doublets does not appear to be con-
stant; this may in part be due to T, and nuclear Overhauser
enhancement differences of the given carbons in each isomer.
The spectrum of warfarin (Fig. 1) is strikingly similar to
the spectrum of cyclocoumarol, 4, and this strongly supports
structure 3 for warfarin in solution. Furthermore, the presence
of two peaks for each carbon in ring C indicates that the sub-
stance is also a mixture of diastereomers. This would not be
possible if warfarin were in the open-chain form 1. The peaks
assigned to C14 (27.3 and 25.9 ppm) have intensity ratios of
about 2:1. The chemical shift of the isomeric methyl carbon
(C14) is expected to be upfield when it occupies an axial
instead of an equatorial position (8). That the major com-
ponent (27.3 ppm) is the more downfield peak of this pair,
indicates therefore that the methyl carbon is equatorial in the
predominant isomer.
Further important evidence for the proposed structure 3
can be deduced from the spectrum of sodium warfarin at pH
9.2 which shows three alkyl peaks (Fig. 1). The doubling pat-
tern which was apparent in compounds 3 and 4 is absent and
this clearly demonstrates that the sodium salt is not a mixture
of two diastereomers and must have the open-chain structure
2. Further evidence of ring opening is provided by the peak
at 216.5 ppm which is clearly a ketone carbon (see chapt. 5 of
ref. 5).
Phenprocoumon, 5, is closely related to the proposed struc-
ture for sodium warfarin and the substances do have similar
carbon-13 spectra, provided account is taken of the absence of
a carbonyl group at C13 in 5. As expected, 5 shows no doubling
of peaks as could be attributed to the presence of diastereo-
mers.
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